Need professional-grade analysis? Visit stockanalysis.com
$4.08B
N/A
174
N/A
Jenscare Scientific Co Ltd (9877) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at HKD9.69, up 2.22% from the previous close.
Over the past year, 9877 has traded between a low of HKD5.22 and a high of HKD11.98. The stock has gained 85.6% over this period. It is currently 19.1% below its 52-week high.
Jenscare Scientific Co Ltd has a market capitalization of $4.08B.
Jenscare Scientific Co., Ltd., a medical device company, engages in the research and development of interventional products for the treatment of structural heart diseases in the People's Republic of China. It offers LuX-Valve and LuX-Valve Plus, a transcatheter tricuspid valve replacement (TTVR) product for the treatment of severe tricuspid regurgitation and high surgical risk; KenFlex, a transcatheter aortic valve intervention (TAVR) repair system product for the treatment of aortic valve regurgitation; and Ken-Valve, a TRVR system for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops JensClip, a clip-based transcatheter mitral valve intervention (TMVR) repair system to treat patients with severe mitral regurgitation; JensRelive, a TMVR system to treat patients with severe mitral regurgitation and replace dysfunctional primary mitral valves without undergoing routine thoracotomy surgery; and SimuLock, a bionics left atrial appendage occluder system for cardiogenic stroke prevention. In addition, it offers platform technologies/accessories comprising introducer kit, JeniGal anti-calcification technology, dry-tissue technology and polymer leaflet technology; and engages in consulting and investment activities. The company was incorporated in 2011 and is headquartered in Ningbo, the People's Republic of China.
Side-by-side comparison against top Healthcare peers.